Corbus Pharmaceuticals Holdings CRBP
NASDAQ CRBP
$8.24 -0.62 (-7.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Corbus Pharmaceuticals Holdings (CRBP) Asset Utilization Ratio (2015 - 2022)

Corbus Pharmaceuticals Holdings (CRBP) posted Asset Utilization Ratio of 0.0 for Q2 2022, down 52.38% on a QoQ basis from 0.0 in Q1 2022, and down 94.66% year-over-year from 0.02 in Q2 2021.

Analysis

Corbus Pharmaceuticals Holdings (CRBP) Asset Utilization Ratio (2015 - 2022) Analysis & Trends

Corbus Pharmaceuticals Holdings has reported Asset Utilization Ratio for 8 years, with the latest figure at 0.0 in Q2 2022.

  • On a quarterly basis, Asset Utilization Ratio fell 94.66% year-over-year to 0.0 in Q2 2022; TTM through Jun 2022 was 0.0, a 94.66% decrease from a year earlier, with the FY2021 full-year figure at 0.01, down 83.85% from the prior year.
  • Asset Utilization Ratio was 0.0 for Q2 2022 at Corbus Pharmaceuticals Holdings, down from 0.0 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.63 in Q1 2020, with the low at 0.0 in Q2 2022.
  • Average Asset Utilization Ratio over 5 years is 0.15, with a median of 0.04 recorded in 2018.
  • The sharpest annual moves came in 2019 and 2021: Asset Utilization Ratio surged 958.8% in 2019, then slumped 96.3% in 2021.
  • Over 5 years, Asset Utilization Ratio stood at 0.09 in 2018, then surged by 591.34% to 0.62 in 2019, then sank by 93.55% to 0.04 in 2020, then tumbled by 80.48% to 0.01 in 2021, then plunged by 85.88% to 0.0 in 2022.
  • The last three Asset Utilization Ratio figures came in at 0.0 (Q2 2022), 0.0 (Q1 2022), and 0.01 (Q4 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 0.40
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 0.58
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 0.47
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 0.38
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 0.20
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 0.90
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 0.33
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 0.00
10 Corbus Pharmaceuticals Holdings 101.29 Mn -61.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.01
Sep 30, 2021 0.01
Jun 30, 2021 0.02
Mar 31, 2021 0.02
Dec 31, 2020 0.04
Sep 30, 2020 0.06
Jun 30, 2020 0.09
Mar 31, 2020 0.63
Dec 31, 2019 0.62
Sep 30, 2019 0.47
Jun 30, 2019 0.37
Mar 31, 2019 0.08
Dec 31, 2018 0.09
Sep 30, 2018 0.04
Jun 30, 2018 0.04
Mar 31, 2018 0.03
Dec 31, 2017 0.05
Sep 30, 2017 0.08